Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (701-710 of 737) with videos related to

Pageof 74
Sort By:
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Blood|August 9, 2013
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patientsAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
The New England Journal of Medicine|July 2, 2015
Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaTetsuichi Yoshizato, Bogdan Dumitriu, Kohei Hosokawa, et al.
Blood|July 5, 2019
Increased SLAMF7<sup>high</sup> monocytes in myelofibrosis patients harboring <i>JAK2</i>V617F provide a therapeutic target of elotuzumabTakaaki Maekawa, Shoichiro Kato, Toshikuni Kawamura, et al.
Nature Genetics|February 19, 2002
Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell functionKiyoto Kurima, Linda M Peters, Yandan Yang, et al.
BMJ Open|April 9, 2022
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Case Reports in Oncology|December 11, 2023
Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular CarcinomaRyoi Yoshida, Keisuke Koroki, Hirokazu Makishima, et al.
Nature Genetics|September 24, 2024
Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevanceQingbo S Wang, Takanori Hasegawa, Ho Namkoong, et al.
Nature Communications|April 26, 2017
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cellsFeng Pan, Thomas S Wingo, Zhigang Zhao, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 74

Showing results (701-710 of 737) with videos related to

Sort By:
Pageof 74
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Blood|August 9, 2013
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patientsAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
The New England Journal of Medicine|July 2, 2015
Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaTetsuichi Yoshizato, Bogdan Dumitriu, Kohei Hosokawa, et al.
Blood|July 5, 2019
Increased SLAMF7<sup>high</sup> monocytes in myelofibrosis patients harboring <i>JAK2</i>V617F provide a therapeutic target of elotuzumabTakaaki Maekawa, Shoichiro Kato, Toshikuni Kawamura, et al.
Nature Genetics|February 19, 2002
Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell functionKiyoto Kurima, Linda M Peters, Yandan Yang, et al.
BMJ Open|April 9, 2022
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Case Reports in Oncology|December 11, 2023
Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular CarcinomaRyoi Yoshida, Keisuke Koroki, Hirokazu Makishima, et al.
Nature Genetics|September 24, 2024
Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevanceQingbo S Wang, Takanori Hasegawa, Ho Namkoong, et al.
Nature Communications|April 26, 2017
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cellsFeng Pan, Thomas S Wingo, Zhigang Zhao, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 74